Korea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic Arthritis

NCT05754710 · clinicaltrials.gov ↗

RECRUITING

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriatic Arthritis, Juvenile
Polyarticular Juvenile Idiopathic Arthritis

Interventions

DRUG: Xeljanz

Sponsor

Pfizer